CHICAGO (GenomeWeb) – A St. Jude Children's Research Hospital-led team has identified a haplotype that appears to coincide with the risk of premature menopause in pediatric cancer survivors treated with gonadotoxic drugs.

Speaking at the American Society of Clinical Oncology here yesterday, Russell Brooke, a postdoctoral researcher in epidemiology and cancer control, presented preliminary findings from a search for variants associated with premature menopause in nearly 800 childhood cancer survivors from the St. Jude Lifetime Cohort.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.